|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/16/2024 |
$266.83 |
$267.51 |
$263.81 |
$265.64 |
2.02M | 04/17/2024 |
$267.54 |
$268.77 |
$263.39 |
$264.07 |
2.18M | 04/18/2024 |
$265.64 |
$265.92 |
$262.58 |
$262.75 |
2.08M | 04/19/2024 |
$264.63 |
$269.38 |
$260.68 |
$268.93 |
3.38M | 04/22/2024 |
$269.84 |
$273.14 |
$269.84 |
$271.91 |
2.17M |
|
Amgen is a biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics. Co.'s principal products are Enbrel® (etanercept), Prolia® (denosumab), Otezla® (apremilast), XGEVA® (denosumab), Neulasta® (pegfilgrastim), Aranesp® (darbepoetin alfa), Repatha® (evolocumab), KYPROLIS® (carfilzomib) and Nplate® (romiplostim). Co. also markets a number of other products, including among other, MVASI® (bevacizumab-awwb), Vectibix® (panitumumab), KANJINTI® (trastuzumab-anns), EVENITY® (romosozumab-aqqg), EPOGEN® (epoetin alfa), BLINCYTO® (blinatumomab), AMGEVITA (adalimumab), Aimovig® (erenumab-aooe), Parsabiv® (etelcalcetide) and NEUPOGEN® (filgrastim). | |
|
Amgen (AMGN) has the following price history information. Looking back at AMGN historical stock prices for the last five trading days, on April 16, 2024, AMGN opened at $266.83, traded as high as $267.51 and as low as $263.81, and closed at $265.64. Trading volume was a total of 2.02M shares. On April 17, 2024, AMGN opened at $267.54, traded as high as $268.77 and as low as $263.39, and closed at $264.07. Trading volume was a total of 2.18M shares. On April 18, 2024, AMGN opened at $265.64, traded as high as $265.92 and as low as $262.58, and closed at $262.75. Trading volume was a total of 2.08M shares. On April 19, 2024, AMGN opened at $264.63, traded as high as $269.38 and as low as $260.68, and closed at $268.93. Trading volume was a total of 3.38M shares. On April 22, 2024, AMGN opened at $269.84, traded as high as $273.14 and as low as $269.84, and closed at $271.91. Trading volume was a total of 2.17M shares.
AMGN Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Amgen shares, starting with a $10,000 purchase of AMGN, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
04/24/2014 |
|
End date: |
04/22/2024 |
|
Start price/share: |
$113.72 |
|
End price/share: |
$271.91 |
|
Starting shares: |
87.94 |
|
Ending shares: |
115.97 |
|
Dividends reinvested/share: |
$56.64 |
|
Total return: |
215.35% |
|
Average Annual Total Return: |
12.17% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$31,543.06 |
|
Years: |
10.00 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/24/2014 |
|
End date: |
04/22/2024 |
|
Start price/share: |
$113.72 |
|
End price/share: |
$271.91 |
|
Dividends collected/share: |
$56.64 |
|
Total return: |
188.91% |
|
Average Annual Total Return: |
11.19% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$28,892.39 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/16/2024 | $265.64 | 04/17/2024 | $264.07 | 04/18/2024 | $262.75 | 04/19/2024 | $268.93 | 04/22/2024 | $271.91 |
|
|